Eimer Pharma Private Limited - Company Profile

It is a pharma private limited company based in Poonithura, Kerala, India, established in 2021.
2021 Poonithura, Kerala, India Active
Last Updated:
Access Report
About Eimer Pharma Private Limited

Eimer Pharma Private Limited, a active private limited company, was established on 15 March 2021 in Poonithura, Kerala, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U52311KL2021PTC068029. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Nasarulla Felsak (Director), Shajil Fasilhak Shahida (Additional Director). Past directors included Musafir Khan Ali Pura, Naseer Kannu Abdul Asees, Parvathy Jamuna Balachandran. It is based at Krishna Kripa, 51/2548 A Karthika Lane, Petta, Poonithura, Kerala, 682019.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U52311KL2021PTC068029

  • Registration Number

    068029

  • Incorporation Date

    15 March 2021

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Ernakulam

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 10 Months
Company report

Eimer Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Eimer Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Eimer Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Nasarulla Felsak Director 15 Mar 2021 Current
Shajil Fasilhak Shahida Additional Director 30 May 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 May 2023 Past
Pramod Abcsdd Director 30 May 2023 Past
Pramod Abcsdd Director 21 May 2022 Past
Pramod Abcsdd Director 30 May 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Eimer Pharma.

Enhance accessibility to Eimer Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Eimer Pharma revenue growth over time
Eimer Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Eimer Pharma?

Unlock access to Eimer Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Eimer Pharma?

Eimer Pharma has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Eimer Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eimer Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Eimer Pharma
Recent Activity within the Organization
  • Director Appointment

    Progress on Shajil Fasilhak Shahida was appointed as a Additional Director was appointed as a Additional Director on 30 May 2023 & has been associated with this company since 2 years 8 months . was documented.

  • Director Appointment

    Nasarulla Felsak was appointed as a Director was appointed as a Director on 15 Mar 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.

  • Company Incorporation

    Eimer Pharma Private Limited was registered on 15 Mar 2021 with Roc Ernakulam & aged 4 years 10 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Eimer Pharma Private Limited?

The CIN of Eimer Pharma Private Limited is U52311KL2021PTC068029.

Where is Eimer Pharma Private Limited headquartered?

Eimer Pharma Private Limited is headquartered at Krishna Kripa, 51/2548 A Karthika Lane, Petta, Poonithura, Kerala, 682019.

When was Eimer Pharma Private Limited incorporated?

Eimer Pharma Private Limited was incorporated on 15 March 2021.

Who are the current directors of Eimer Pharma Private Limited?

The current directors of Eimer Pharma Private Limited are

What is the primary industry of Eimer Pharma Private Limited?

The primary industry of Eimer Pharma Private Limited is Pharma.

Is Eimer Pharma Private Limited a listed company?

Eimer Pharma Private Limited is unlisted.

What is the capital structure of Eimer Pharma Private Limited?

The authorized capital of Eimer Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available